Molecular mechanisms of multidrug resistance in cancer chemotherapy

Pathology Research and Practice

Volumn 192, Issue 7, 1996, Pages 768-780

  Nooter, K ^a,b   Stoter, G ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Circumvention of MDR; Clinical relevance; Multidrug resistance (MDR); Multidrug resistance gene (MDR1); Multidrug resistance associated protein (MRP); P glycoprotein (Pgp)

Indexed keywords

CARRIER PROTEIN; GLYCOPROTEIN; GLYCOPROTEIN P;

CANCER CHEMOTHERAPY; CROSS RESISTANCE; DRUG ACCUMULATION; GENE CONTROL; HUMAN; MEMBRANE BINDING; MULTIDRUG RESISTANCE; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0029759985     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(96)80099-9     Document Type: Article

References (141)

1. Abbaszadegan MR, Futscher BW, Klimecki WT, List A, Dalton WS (1994) Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res 54: 4676-4679
2. Akiyama S, Cornwall MM, Kuwano M, Pastan I, Gottesman MM (1988) Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Mol Pharmacol 33: 144-147
3. r 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res 55: 102-110
4. Ames GF, Lecar H (1992) ATP-dependent bacterial transporters and cystic fibrosis: analogy between channels and transproters. FASEB J 6: 2660-2666
5. Azzaria M, Schurr E, Gros P (1989) Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish to confer multidrug resistance. Mol Cell Biol 9: 5289-5297
6. Baas F, Jongsma APM, Broxterman HJ, Arceci RJ, Housman D, Scheffer GL, Riethorst A, van Groeningen M, Nieuwint AWM, Joenje H (1990) Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer celll line. Cancer Res 50: 5392-5398
7. Barrand MA, Rhodes T, Center MS, Twentyman PR (1993) Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190 k membrane protein distinct from P-glycoprotein. Eur J Cancer 29A-408-415
8. Barrand MA, Heppell-Parton AC, Wright KA, Rabbitts PH, Twentyman PR (1994) A 190-Kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J Natl Cancer Inst 86: 110-117
9. Beck J, Niethammer D, Gekeler V (1994) High mdr1-and mrp-, but low topoisomerase IIα-gene expression in B-cell chronic lymphocytic leukaemias. Cancer Lett 86: 135-142
10. Bhalla K, Hindenburg A, Taub RN, Grant S (1985) Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res 45: 3657-3662
11. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM, Norris MD (1994) Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 54: 503-5040
12. Bourhis J, Goldstein LJ, Riou G, Pastan I, Gottesman MM, Bénard J (1989a) Expression of a human multidrug resistance gene in ovarian carcinomas. Cancer Res 49: 5062-5065
13. Bourhis J, Bernard J, Hartmann O, Boccon-Gibod L, Lemerle J, Riou G (1989b) Correlation of mdr1 gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst 81: 1401-1405
14. Brown PC, Thorgeirsson SS, Silverman JA (1993) Cloning and regulation of the rat mdr2 gene. Nucleic Acids Res 21: 3885-3891
15. Burger H, Nooter K, Zaman GJR, Sonneveld P, van Wingerden KE, Oostrum RG, Stoter G (1994a) Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia 8: 990-997
16. Burger H, Nooter K, Sonneveld P, van Wingerden KE, Zaman GJR, Stoter G (1994b) High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukemia. Br J Haematol 88: 348-356
17. Buschman E, Gros P (1994) The inability of the mouse mdr1 gene to confer multidrug resistance is linked to reduced drug binding to the protein. Cancer Res 54: 4892-4898
18. Callahan HL, Beverley SM (1991) Heavy metal resistance: a new role for P-glycoproteins in Leishmania. J Biol Chem 266: 18427-18430
19. Callen DE, Baker E, Simmers RN, Seshadri R, Roninson IB (1987) Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. Hum Genet 77: 142-144
20. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 79: 473-476
21. Center MS (1993) Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug. Cytotechnology 12: 109-125
22. Chan HSL, Thorner PS, Haddad G, Ling V (1990) Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8: 689-704
23. Chan HSL, Haddad G, Thorner PS, DeBoer G, Lin YP, Ondrusek N, Yeger H, Ling V (1991) P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 325: 1608-1614
24. Chaudhary PM, Roninson IB (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66: 85-94
25. Chen C, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381-389
26. Childs S, Ling V (1994) The MDR superfamily of genes and its biological implications. In: DeVita VT, Hellman S, Rosenberg SA (Eds.) Important Advances in Oncology, pp. 21-36. Lippincott, Philadelphia
27. Chin JE, Soffir R, Noonan KE, Choi, Roninson IB (1989) Structure and expression of the human MDR (P-glycoprotein) gene family. Mol Cell Biol 9: 3808-3820
28. Choi K, Chen C, Kriegler M, Roninson IB (1988) An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr-1 (P-glycoprotein) gene. Cell 53: 520-529
29. Cole SPC, Chanda ER, Dicke FP, Gerlach JH, Mirski SEL (1991) Non-P-glycoprotein-mediated multidrug resistance in a small lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. Cancer Res 51: 3345-3352
30. Cole SPC (1992) The 1991 Merck Frosst award. Multidrug resistance in small cell lung cancer. Can J Physiol Pharmacol 70: 313-329
31. Cole SPC, Bhardwaj G, Gerlalch JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654
32. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902-5910
33. Cordon-Cardo C, O'Brien JP, Cassals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86: 695-698
34. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR (1990) Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38: 1277-1287
35. Croop JM (1993) P-glycoprotein structure and evolutionary homologies. Cytotechnology 13: 1-32
36. Currier SJ, Ueda K, Willmgham MC, Pastan I, Gottesman MM (1989) Deletion and insertion mutants of the multidrug transporter. J Biol Chem 264: 14376-14381
37. Davey RA, Longhurst TJ, Davey MW,I Belov L, Harvie RM, Hancox D, Wheeler H (1995) Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line. Leukemia Res 19: 275-282
38. Deuchars KL, Duthie M, Ling V (81992) Identification of distinct P-glycoprotein gene sequences in rat. Biochim Biophys Acta 1130: 157-165
39. Devault A, Gros P (1990) Two members of the mouse MDR gene family confer multidrug resistance with overlapping but distinct drug specificity. Mol Cell Biol 10: 1652-1663
40. Devine SE, Ling V, Melera PW (1992) Amino acid substitutions in the sixth transmembrane domain of P-glycoprotein alter multidrug resistance. Proc Natl Acad Sci USA 89: 4564-4568
41. Dhir R, Gros P (1992) Functional analysis of chimeric proteins constructed by exchanging homologous domains of 2 P-glycoproteins conferring distinct drug resistance profiles. Biochemistry 31: 6103-6110
42. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreeff M (1992) Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80: 2729-2734
43. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJLM, Scheper RJ, Zaman GJR (1994) Immunochemical detection of multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 54: 4557-4563
44. Foote SJ, Thompson JK, Cowman AF, Kemp DJ (1989) Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57: 921-930
45. Ford JM, Hait WN (1993) Pharmacological circumvention of multidrug resistance. Cytotechnology 12: 171-212
46. Foxwell BMJ, Mackie A, Ling V, Ryffel B (1989) Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. Mol Pharmacol 36: 543-546
47. Gekeler V, Frese G, Noller A, Handgretinger R, Wilisch A, Schmidt H, Muller CP, Dopfer R, Klingebiet T, Diddens H, Probst H, Neithammer D (1992) MDR 1/P-glycoprotein, topoisomerase and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias. Br J Cancer 66: 507-517
48. 4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem Biophys Res Common 208: 345-352
49. Gerlach JH, Endicott JA, Juranka PF, Henderson G, Sarangi F, Deuchars KL, Ling V (1986) Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug-resistance. Nature 324: 485-489
50. Germann UA (1993) Molecular analysis of the multidrug transporter. Cytotechnology 12: 33-62
51. Goasguen JE, Dossot JM, Fardel O, Le Mee F, Le Gall E, Leblay R, Leprise PY, Chaperon J, Fauchet R (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia prognostic implications. Blood 81: 2394-2398
52. Goldstein LJ, Galski H, Fojo AT, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Grist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116-124
53. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427
54. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357-361
55. Grogan TM, Spier CM, Salmon SE, Matzner M, Rybski J, Weinstein RS, Scheper RJ, Dalton WS (1993) P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. Blood 81: 49-495
56. Gros P, Croop J, Housman D (1986) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380
57. Gros P, Raymond M, Bell J, Housman D (1988) Cloning and characterization of a second member of the mouse mdr gene family. Mol Cell Biol 8: 2770-2778
58. Gros P, Dhir R, Croop T, Talbot F (1991) A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proc Natl Acad Sci USA 88: 7289-7293
59. Guerci A, Merlin JL, Missoum N, Feldmann L, Marchal S, Witz F, Rose C, Guerci O (1995) Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood 85: 2147-2153
60. Hamada H, Tsuruo T (1988) Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res 48: 4926-4932
61. Herweijer H, Sonneveld P, Baas F, Nooter K (1990) Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 82: 1133-1140
62. Higgins CF (1992) ABC transporters from microorganisms to man. Annu Rev Cell Biol 8: 67-113
63. Hill BT (1993) Differing patterns of cross-resistance resulting from exposure to specific antitumor drugs or to radiation in vitro. Cytotechnology 12: 265-288
64. Hipfner DR, Gauldie SD, Deeley RG, Cole SPC (1994) Detection of the Mr 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res 54: 5788-5792
65. Hofmann GA, Mattern MR (1993) Topoisomerase II in multiple drug resistance. Cytotechnology 12: 137-154
66. Holmes J, Wareing C, Jacobs A, Hayes JD, Padua RA, Wolf CR (1990) Glutathione-s-transferase pi expression in leukemia: a comparative analysis with mdr1 data. Br J Cancer 62: 209-212
67. Horio M, Gottesman MM, Pastan I (1988) ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci USA 85: 3580-3584
68. Hsu SI, Lothstein L, Horwitz SB (1989) Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. J Biol Chem 264: 12053-12062
69. Jachez B, Nordmann R, Loor F (1993) Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446. J Natl Cancer Inst 85: 478-483
70. Jedlitschky G, Leier I, Buchholz U, Center M, Keppler D (1994) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54: 4833-4836
71. Johnston JB, Israels LG, Goldenberg GJ, Anhalt CD, Verburg L, Mowat MR A, Begleiter A (1990) Glutathione S-transferase activity, sulfhydryl group and glutathione levels, and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia. J Natl Cancer Inst 82: 776-779
72. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162
73. Juranka PF, Zastawny RL, Ling V (1989) P-glycoprotein: multidrug resistance and a family of membrane-associated transport proteins. FASEB J 3: 2583-2592
74. Kaufmann SH, Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ (1994) Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood 83: 517-530
75. Keller RP, Altermatt HJ, Donatsch P, Zihlmann H, Laissue JA, Hiestand PC {1992) Pharmacologic interactions between the resistance-modifying cyclosporine SDZ PSC 833 and etoposide (VP 16-213) enhance m vivo cytostatic activity and toxicity. Int J Cancer 51: 433-438
76. Krishnamachary N, Center MS (1993) The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 53: 3658-3661
77. Kruh GD, Chan A, Myers K, Gaughan K, Miki A, Aaronson SA (1994) Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res 54: 1649-1652
78. 4 and structurally related conjugates. J Biol Chem 269: 27807-27810
79. Lincke CR, van der Bliek AM, Schuurhuis GJ, van der Velde-Koerts T, Smit JJM, Borst P (1990) Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. Cancer Res 50: 1779-1785
80. List AF, Spier C, Greer J, Wolff S, Hutter J, Dorr R, Salmon S, Futscher B, Baier M, Dakon W (1993) Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 11: 1652-1660
81. Liu LF (1989) DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58: 351-357
82. Lutzky J, Astor MB, Taub RN, Baker MA, Gervasoni JE, Rosado V, Stewart V, Krishna S, Hindenburg AA (1989) Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Cancer Res 49: 4120-4125
83. Marie JP, Zittoun R, Sikic BI (1991) Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 78: 58-592
84. Marie JP, Bastie JN, Coloma F, Suberville AM, Delmer A, Rio B, Delmas-Marsalet B, Leroux G, Casassus P, Baumelou E, Catalin J, Zittoun R (1993) Cyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL). Leukemia 7: 821-824
85. Marquardt D, Center MS (1992) Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells. Cancer Res 52: 315-3163
86. McGrath JP, Varshavsky A (1989) The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature 340: 400-404
87. McKenna SL, Whittaker JA, Padua RA, Holmes JA (1993) Topoisomerase II expression in normal haemopoietic cells and chronic lymphocytic leukaemia: drug sensitivity or resistance. Leukemia 7: 1199-1203
88. Miller TP, Grogan TM, Dalton WS, Spier CM, Scheper RJ, Salmon SE (1991 ) P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. J Clin Oncol 9: 17-24
89. Mirski SEL, Gerlach JH, Cole SPC (1987) Multidrug resistance in a human small cell lung cancer cell line selected in Adriamycin. Cancer Res 47: 2594-2598
90. Müller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, de Vries EGE, Jansen PLM (1994) Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione 5-conjugate transport. Proc Natl Acad Sci USA 91: 13033-13037
91. Nielsen D, Skovsgaard T (1992) P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochem Biophys acta 1139: 169-183
92. Ng WF, Sarangi F, Zastawny RL, Veinot-Drebot L, Ling V (1989) Identification of members of the P-glycoprotein multigene family. Mol Cell Biol 9: 1224-1232
93. Nooter K, Oostrum R, Jonker R, van Dekken H, Stokdijk W, van den Engh G (1989) Effect of cyclosporin a on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry. Cancer Chemother Pharmacol 23: 296-300
94. Nooter K, Herweijer H (1991) Multidrug resistance (mdr) genes in human cancer. Br J Cancer 63: 663 -669
95. Nooter K, Sonneveld P (1993) Multidrug resistance (MDR) genes in hematological malignancies. Cytotechnology 12: 213-230
96. Nooter K, Sonneveld P (1994) Clinical relevance of P-glycoprotein expression in hematological malignancies. Leukemia Res 18: 233-243
97. Nooter K, Westerman AM, Flens MJ, Zaman GJR, Scheper RJ, van Wingerden KE, Burger H, Oostrum R, Boersma T, Sonneveld P, Gratama JW, Kok T, Eggermont MM, Bosman FT, Stoter G (1995a) Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1: 1301-1310
98. Nooter K, Burger H, Stoter G (1995b) Multidrug resistance-associated protein (MRP) in haematological malignancies. Leuk Lymphoma 18: 179-184
99. Nooter K, Bosman FT, Burger H, van Wingerden KE, Flens MJ, Scheper RJ, Oostrum RG, Boersma AWM, van der Gaast A, Stoter G (1996) Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small cell lung cancer. Ann Oncol 7: 75-81
100. Nooter K, unpublished results
101. Potmesil M, Hsiang YH, Liu LF, Bank B, Grossberg H, Kirschenbaum S, Forlenzar TJ, Penziner A, Kanganis D, Knowles D, Traganos F, Silber R (1988) Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. Cancer Res 48: 3537-3543
102. Raderer M, Scheithauer W (1993) Clinical trials of agents that reverse multidrug resistance. Cancer 72: 3553-3563
103. Raymond M, Gros P, Whiteway M, Thomas DY (1992) Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene. Science 256: 232-234
104. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC (1989) Identification of the cystic fibrosis gene: cloning and charachterization of complementary DNA. Science 245: 1066-1073
105. Rodenburg CJ, Nooter K, Herweijer H, Seynaevec C, Oosterom R, Stoter G, Verweij J (1991) Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer. Ann Oncol 2: 305-306
106. Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, Shen DW, Gottesman MM, Pastan I (1986) Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83: 4538-4542
107. Ruetz S, Gros P (1994) Phospharidykholine translocase: a physiological role for the mdr2 gene. Cell 77: 1071-1082
108. Schinkel AH, Roelofs MEM, Borst P (1991) Charaterization of the human mdr3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res 51: 2628-2635
109. Schinkel A, Kemp S, Dolle M, Rudenko G, Wagenaar E (1993) N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. J Biol Chem 268: 7474-7481
110. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM, Borst P (1994) Disruption of the mouse mdr1 a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491-502
111. Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH (1994) Multidrug resistance-associated protein overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide esistance. Cancer Res 54: 152-158
112. Schneider E, Yamazaki H, Sinha BK, Cowan KH (1995a) Buthionine sulfoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation. Br J Cancer 71: 738-743
113. Schneider E, Cowan KH, Bader H, Toomey S, Schwartz G, Karp JE, Burke PJ, Kaufmann SH (1995b) Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 85: 186-193
114. Silverman JA, Raunio H, Gant TW, Thorgeirsson SS (1991) Cloning and characterization of a member of the rat multidrug resistance (mdr) gene family. Gene 106: 229-236
115. Slovak ML, Hoeltge GA, Dalton WS, Trent JM (1988) Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Cancer Res 48: 2793-2797
116. Slovak ML, Pelkey HJ, Bhardwaj G, Kurz EU, Deeley RG, Cole SPC (1993) Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res 53: 3221-3225
117. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, Ottenhoff R, van der Lugt NMT, van Roon MA, van der Valk MA, Offerhaus GJA, Berns AJA, Borst P (1993) Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75: 451-462
118. Sonneveld P, Nooter K (1990) Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia. Br J Haematol 75: 208-211
119. Sonneveld P, Durie BGM, Lokhorst HM, Marie JP, Solbu G, Suciu S, Zottoun R, Lowenberg B, Nooter K (1992) Modulation of multidrug resistant multiple myeloma by cyclosporin. Lancet 340: 255-259
120. Sonneveld P, Schoester M, de Leeuw K (1994) Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells. J Clin Oncol 12: 1584-1591
121. Stein WD, Cardarelli C, Pastan I, Gottesman MM (1994) Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substates. Mol Pharmacol 45: 763-772
122. Tew KD (1994) Glutathione-associated enzymes in anticancer drug restance. Cancer Res 54: 4313-4320
123. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738
124. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1989) Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein. J Histochem Cytochem 37: 159-164
125. Thomas GA, Barrand MA, Stewart S, Rabbitts PH, Williams ED, Twentyman PR (1994) Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissues as determined by in situ hybridisation. Eur J Cancer 30A: 1705-1709
126. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y ( 1981 ) Over-coming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verypamil. Cancer Res 41: 1967-1972
127. Twentyman PR (1992) Cyclosporins as drug resistance modifiers. Biochem Biopharmacol 43: 109-117
128. Twentyman PR, Rhodes T, Rayner S (1994) A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Eur J Cancer 30A: 1360-1369
129. Ueda K, Cardarelli C, Gottesman MM, Pastan I (1987) Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84: 3004-3008
130. van der Bliek AM, Baas F, ten Houte-de Lange T, Kooiman PM, van der Velde-Koerts T, Borst P (1987) The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. EMBO J 6: 3325-3331
131. van der Bliek AM, Kooiman PM, Schneider C, Borst P (1988) Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene 71: 401-411
132. van der Valk P, van Kalken CK, Ketelaars H, Broxterman HJ, Scheffer G, Kuiper CM, Tsuruo T, Lankelma J, Meijer CJLM, Pinedo HM, Scheper RJ (1990) Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Ann Oncol 1: 56-64
133. Van der Zee AGJ, Hollema H, De Jong S, Boonstra H, Gouw A, Willemse PHB, Zijlstra JG, de Vries EGE (1991 ) P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant of the ovary, before and after platinum/cyclophosphamide chemotherapy. Cancer Res 51: 5915-5920
134. Van der Zee AGJ, de Jong S, Keith WN, Hollema H, Boonstra H, de Vries EGE (1994) Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors. Cancer Res 54: 749-755
135. Versantvoort CHM, Broxterman HJ, Pinedo HM, de Vries EGE, Feller N, Kuiper CM, Lankeima J (1992) Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Res 52: 17-23
136. Verwey J, Herweijer H, Oosterom R, Van der Burg MEL, Planting ASTh, Seynaeve C, Stoter G, Nooter K (1991) A phase II study of epidoxorubucin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance. Br J Cancer 64: 361-364
137. Yuen AR, Sikic BI (1994) Multidrug resistance in lymphomas. J Clin Oncol 12: 2453-2459
138. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, de Haas M, Smith AJ, Broxterman HJ, Mulder NH, de Vries EGE, Baas F, Forst P (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53: 1747-1750
139. Zaman GJR, Flens MJ, van Leusden MR, de Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822-8826
140. Zaman GJR, personal communication
141. Zijlstra JG, de Vries EGE, Mulder NH (1987) Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 47: 1780-1784